午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ShangHai Biochempartner Co.,Ltd

ShangHai Biochempartner Co.,Ltd

Current Location: HOME >> Product
Product Categories
Country: China
Tel: 177-54423994
Mobile: 17754423994
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
CCG-100602 C21H17ClF6N2O2 1207113-88-9 Details
SP-8356 C18H20O4 1454885-45-0 Details
tert-butyl 4-(4-((2,6-dioxopiperidin-3-yl)amino)phenyl)piperidine-1-carboxylate C21H29N3O4 2259851-32-4 Details
Tert-butyl [2-(4-amino-1H-pyrazol-1-yl)ethyl]carbamate oxalate C12H20N4O6 1965304-61-3 Details
5,6-Dibromo-2,3-dimethylpyridine C7H7Br2N 117846-56-7 Details
3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- C14H10N4O4S 1821309-39-0 Details
DGKα inhibitor CU-3 C16H12N2O4S3 1815598-71-0 Details
SHP389 C23H29ClN8O2 2235394-90-6 Details
Upadacitinib hemihydrate C17H21F3N6O2 2050057-56-0 Details
Lipoxamycin hemisulfate C19H38N2O9S 11075-87-9 Details
eIF4A3-IN-1 C29H23BrClN5O2 2095486-67-0 Details
Simufilam dihydrochloride C15H22ClN3O 2480226-06-8 Details
(R)-Methyl 3-(5-bromopyridin-2-YL)-2-(boc-amino)propanoate C14H19BrN2O4 1391465-94-3 Details
2-(4-Bromo-2,6-dimethylphenyl)acetonitrile C10H10BrN 205035-09-2 Details
Methyl 10,11-dihydro-5H-dibenzo[b,f]azepine-4-carboxylate C16H15NO2 22965-12-4 Details
SSD114 C18H20F3N3O 554428-55-6 Details
1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester C22H28N4O5 2222120-27-4 Details
NL-1 C18H25NO3S 188532-26-5 Details
CTB C16H13ClF3NO2 451491-47-7 Details
Poloxin C18H19NO3 321688-88-4 Details
2-(Acetylamino)-5-chlorobenzenesulfonate Pyridine C8H8ClNO4S 54981-41-8 Details
Buspirone EP Impurity C C20H30N8 257877-45-5 Details
Doxazosin Impurity C C22H22N2O6 617677-53-9 Details
Pactimibe (sulfate) C25H42N2O7S 608510-47-0 Details
AMP-945 C28H32F3N5O2 1393653-34-3 Details
ML 145 C24H22N2O5S2 1164500-72-4 Details
(R)-3-Phenylcyclohexanone C12H14O 34993-51-6 Details
(S)-3-Phenylcyclohexanone C12H14O 57344-86-2 Details
Methyl (2S)-3-(5-bromopyridin-2-yl)-2-[(2-methylpropan-2- yl)oxycarbonylamino]-propanoate C14H19BrN2O4 656801-27-3 Details
Tivozanib hydrochloride hydrate C22H22Cl2N4O6 682745-41-1 Details
1-Piperidineacetic acid, 4-[4-[(2,6-dioxo-3-piperidinyl)amino]phenyl]-, 1,1-dimethylethyl ester C22H31N3O4 2641512-32-3 Details
GSK3685032 C22H24N6OS 2170137-61-6 Details
TSHR antagonist S37 C25H20N2O3S2 1217616-61-9 Details
(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)phenyl)methanamine C9H10FN5O 1821248-00-3 Details
NE10790 C8H10NO6P 152831-36-2 Details
FLT3-IN-3 C27H38N8O 2229050-90-0 Details
WAY-181187 hydrochloride C15H14Cl2N4O2S2 554403-08-6 Details
4-[2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1Hisoindol-5-yl]-, 1,1-dimethylethyl ester-1-Piperazinecarboxylic acid C22H25FN4O6 2222116-02-9 Details
PBD dimer C42H39N5O7 1222490-34-7 Details
Phentolamine Analogue 1 C17H19N3O 47142-51-8 Details
Apixaban Impurity 38 C10H16Cl2O3 1802522-36-6 Details
TY-52156 C18H19Cl2N3O 934369-14-9 Details
6-Cyclopropyl-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid C13H15N3O2 851288-57-8 Details
Ebastine Impurity G C32H39NO3 1429071-65-7 Details
Budesonide Impurity 7 C23H28O7 3949-79-9 Details
UNC6934 C24H21N5O4 2561494-77-5 Details
Ebastine Impurity F C32H39NO3 1429071-63-5 Details
TBI-166 C32H30F3N5O3 1353734-12-9 Details
Daunomycinone C21H18O8 21794-55-8 Details
CR8, (R)-Isomer C24H29N7O 294646-77-8 Details
FIDAS-3 C16H15F2N 1266684-01-8 Details
BMS-986176 C19H23F4N3O 1815613-42-3 Details
Tefibazumab 521079-87-8 Details
Yttrium (90Y) Tacatuzumab Tetraxetan 476413-07-7 Details
Bapineuzumab 648895-38-9 Details
Rilotumumab 872514-65-3 Details
(R)-CR8 trihydrochloride C24H30ClN7O 1786438-30-9 Details
SJ-172550 C22H21ClN2O5 431979-47-4 Details
Ibalizumab 680188-33-4 Details
Otelixizumab 881191-44-2 Details
Tigatuzumab 918127-53-4 Details
Panobacumab 885053-97-4 Details
NVR-3-778 C18H16F4N2O4S 1445790-55-5 Details
I-BET567 C17H18ClN5O2 1887237-54-8 Details
Raxibacumab 565451-13-0 Details
Pagibaximab 595566-61-3 Details
Sontuzumab 372075-37-1 Details
Iratumumab 640735-09-7 Details
Disitamab Vedotin 2136633-23-1 Details
Edrecolomab 156586-89-9 Details
Libivirumab 569658-79-3 Details
SIS3 C28H27N3O3 1009104-85-1 Details
YH53 C30H33N5O5S 1471484-62-4 Details
7-O-(Triethylsilyl) Baccatin III C37H52O11Si 115437-21-3 Details
GSK 2033 C29H28F3NO5S2 1221277-90-2 Details
RGD Trifluoroacetate C14H23F3N6O8 2378808-45-6 Details
EIT hydrobromide C3H9BrN2S 1071-37-0 Details
Besilesomab 537694-98-7 Details
Volociximab 558480-40-3 Details
BVT948 C14H11NO3 39674-97-0 Details
HLY78 C17H17NO2 854847-61-3 Details
Exbivirumab 569658-80-6 Details
Robatumumab 934235-44-6 Details
elsilimomab 468715-71-1 Details
Teneliximab 395639-53-9 Details
Pritumumab 499212-74-7 Details
Oxelumab 1186098-83-8 Details
Olokizumab 1007223-17-7 Details
Elotuzumab 915296-00-3 Details
Anatumomab Details
Vapaliximab 336801-86-6 Details
Reslizumab 241473-69-8 Details
Ecromeximab 292819-64-8 Details
Erlizumab 211323-03-4 Details
Figitumumab 943453-46-1 Details
Farletuzuma 896723-44-7 Details
Cixutumumab 947687-12-9 Details
Lemalesomab 250242-54-7 Details
Sibrotuzumab 216669-97-5 Details
Bivatuzumab Details
Product Total: Product Page:
47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80